FDG-PET Imaging for Oxidized LDL in Stable Atherosclerotic Disease: A Phase II Study of Safety, Tolerability, and Anti-Inflammatory Activity

Saved in:

Bibliographic Details
Published in	JACC. Cardiovascular imaging Vol. 8; no. 4; pp. 493 - 494
Main Authors	Lehrer-Graiwer, Joshua, Singh, Parmanand, Abdelbaky, Amr, Vucic, Esad, Korsgren, Magnus, Baruch, Amos, Fredrickson, Jill, van Bruggen, Nick, Tang, Meina T., Frendeus, Bjorn, Rudd, James H.F., Hsieh, Frank, Ballantyne, Christie M., Ghoshhajra, Brian, Rosenson, Robert S., Koren, Michael, Roth, Eli M., Duprez, Daniel A., Fayad, Zahi A., Tawakol, Ahmed A.
Format	Journal Article
Language	English
Published	United States Elsevier Inc 01.04.2015
Subjects	Antibodies, Monoclonal Atherosclerosis - diagnostic imaging Atherosclerosis - drug therapy Biomarkers - blood Cardiovascular Double-Blind Method Female Fluorodeoxyglucose F18 Humans Lipoproteins, LDL - antagonists & inhibitors Male Middle Aged Positron-Emission Tomography - methods Radiopharmaceuticals Recombinant Proteins
Online Access	Get full text
ISSN	1936-878X 1876-7591 1876-7591
DOI	10.1016/j.jcmg.2014.06.021

More Information
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 ObjectType-Correspondence-3 content type line 23 ObjectType-Undefined-4
ISSN:	1936-878X 1876-7591 1876-7591
DOI:	10.1016/j.jcmg.2014.06.021